Hosted on MSN1mon
Trial finds monoclonal antibody therapy improves survival in cancer-associated hyper-inflammatory disorderData from the Phase Ib trial were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition by Abhishek Maiti, M.D., assistant professor of Leukemia and the trial's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback